Bard Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Bard Associates's JNJ Position: Q2 2026 in Review
Bard Associates reduced its Johnson & Johnson (JNJ) stake by 15% in Q2 2026, selling an estimated $5.13K and leaving 125 shares worth $31.7K. The position accounts for 0.01% of the portfolio, ranked #189.
Bard Associates first reported a position in JNJ in Q1 2026 and has held it in 2 quarters since. The position peaked at $35.9K in Q1 2026. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Bard Associates held 125 shares of Johnson & Johnson worth $31.7K as of Q2 2026.
- Bard Associates sold 22 Johnson & Johnson shares in Q2 2026, an estimated $5.13K.
- Johnson & Johnson made up 0.01% of Bard Associates's portfolio in Q2 2026, its #189 holding.
- Bard Associates first reported a position in Johnson & Johnson in Q1 2026 and has held it in 2 quarters since.
- Bard Associates's Johnson & Johnson position peaked at $35.9K in Q1 2026.
- 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.